Abstract
Introduction: Short chain fatty acids (SCFA) are gut microbiota-derived metabolites that contribute to the gut-brain axis and may impact stroke outcomes following gut dysbiosis. We evaluated plasma SCFA concentrations against stroke severity parameters and identified SCFA-associated protein networks.
Methods: The Blood and Clot Thrombectomy Registry and Collaboration (BACTRAC), a continuously enrolling tissue bank, was used to obtain stroke samples. Arterial blood distal and proximal to the thrombus was obtained from Acute Ischemic Stroke (AIS) Patients (n=53) during thrombectomy. Patient demographics, stroke presentation and outcome parameters were reported. The SCFAs were isolated from proximal plasma via chemical derivatization UHPLC coupled tandem mass spectrometry using electrospray ionization and multiple reaction monitoring. Proteomic levels for 184 cardioembolic and inflammatory proteins was quantified from systemic and intracranial plasma by Olink. Arterial blood from cerebrovascular patients undergoing elective neurointerventional procedures was used as controls.
Results: Acetate positively correlated with time from last known normal (LKN) and was significantly lower in stroke patients compared to control. Isobutyrate, Butyrate and 2-Methylbutyrate negatively correlated with %ΔNIHSS. Isobutyrate and 2-Methylbutyrate positively correlated with NIHSS discharge. SCFA concentrations were not associated with NIHSS admission, infarct volume, or edema volume. Multiple SCFAs positively associated with systemic and pro-inflammatory cytokines, most notably IL-6, TNF-α, VCAM1, IL-17, and MCP-1.
Conclusions: Plasma SCFA concentrations taken at time of stroke are not associated with stroke severity at presentation. However, higher levels of SCFAs at the time of stroke are associated with increased markers of inflammation, less recovery from admission to discharge, and worse symptom burden at discharge.
Document Type
Article
Publication Date
1-19-2022
Digital Object Identifier (DOI)
https://doi.org/10.3389/fimmu.2021.797302
Funding Information
Department of Neurology, University of Kentucky
Related Content
The original contributions presented in the study are publicly available. This data can be found here: https://figshare.com/articles/dataset/BACTRAC_SCFA_Data_xlsx/17054096/1.
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2021.797302/full#supplementary-material It is also available for download as the additional file listed at the end of this record.
Repository Citation
Henry, Nicholas; Frank, Jacqueline A.; McLouth, Christopher J.; Trout, Amanda L.; Morris, Andrew J.; Chen, Jianzhong; Stowe, Ann M.; Fraser, Justin F.; and Pennypacker, Keith R., "Short Chain Fatty Acids Taken at Time of Thrombectomy in Acute Ischemic Stroke Patients Are Independent of Stroke Severity But Associated with Inflammatory Markers and Worse Symptoms at Discharge" (2022). Behavioral Science Faculty Publications. 76.
https://uknowledge.uky.edu/behavsci_facpub/76
Included in
Behavior and Behavior Mechanisms Commons, Neurology Commons, Neurosciences Commons, Neurosurgery Commons, Radiology Commons
Notes/Citation Information
Published in Frontiers in Immunology, v. 12, article 797302.
© 2022 Henry, Frank, McLouth, Trout, Morris, Chen, Stowe, Fraser and Pennypacker
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.